ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Execupharm UK Limited

Execupharm UK Limited is a dissolved company incorporated on 28 March 2012 with the registered office located in Basingstoke, Hampshire. Execupharm UK Limited was registered 13 years ago.
Status
Dissolved
Dissolved on 6 February 2024 (1 year 7 months ago)
Was 11 years old at the time of dissolution
Via voluntary strike-off
Company No
08010260
Private limited company
Age
13 years
Incorporated 28 March 2012
Size
Small
Turnover is under £15M
Balance sheet is under £7.5M
Under 50 employees
Confirmation
Not Submitted
Awaiting first confirmation statement
Accounts
Not Submitted
Awaiting first accounts
Contact
Address
Hart House
C/O Lawrence Young, Priestley Road
Basingstoke
RG24 9PU
United Kingdom
Same address for the past 8 years
Telephone
Unreported
Email
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
2
Director • Secretary • Business Executive • American • Lives in United States • Born in Oct 1969
Director • Business Executive • American • Lives in United States • Born in Jun 1966
Parexel International Corporation Ltd
PSC
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Parexel MMS Europe Limited
Michael Francis Crowley Iii is a mutual person.
Active
Parexel International Limited
Michael Francis Crowley Iii is a mutual person.
Active
Heron Evidence Development Limited
Michael Francis Crowley Iii is a mutual person.
Dissolved
Heron Group Limited
Michael Francis Crowley Iii is a mutual person.
Dissolved
Parexel International (UK) Limited
Michael Francis Crowley Iii is a mutual person.
Dissolved
Parexel International Holding UK Limited
Michael Francis Crowley Iii is a mutual person.
Liquidation
Financials
Net Assets, Total Assets & Total Liabilities (2012–2021)
Period Ended
31 Dec 2021
For period 31 Dec31 Dec 2021
Traded for 12 months
Cash in Bank
£1.44M
Increased by £1.33M (+1295%)
Turnover
£4.04M
Decreased by £5.33M (-57%)
Employees
29
Increased by 13 (+81%)
Total Assets
£2.11M
Decreased by £453K (-18%)
Total Liabilities
-£775K
Decreased by £726K (-48%)
Net Assets
£1.34M
Increased by £273K (+26%)
Debt Ratio (%)
37%
Decreased by 21.82% (-37%)
Latest Activity
Voluntarily Dissolution
1 Year 7 Months Ago on 6 Feb 2024
Voluntary Gazette Notice
1 Year 9 Months Ago on 21 Nov 2023
Application To Strike Off
1 Year 9 Months Ago on 13 Nov 2023
Confirmation Submitted
2 Years 5 Months Ago on 14 Mar 2023
Michael Francis Crowley Iii Details Changed
2 Years 6 Months Ago on 9 Mar 2023
Michael Francis Crowley Iii Details Changed
2 Years 6 Months Ago on 3 Mar 2023
Notification of PSC Statement
2 Years 8 Months Ago on 10 Jan 2023
Parexel International Corporation Ltd. (PSC) Resigned
2 Years 8 Months Ago on 1 Jan 2023
Small Accounts Submitted
2 Years 11 Months Ago on 30 Sep 2022
Mr Paul Joseph Armstrong Appointed
3 Years Ago on 12 Aug 2022
Get Credit Report
Discover Execupharm UK Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 6 Feb 2024
First Gazette notice for voluntary strike-off
Submitted on 21 Nov 2023
Application to strike the company off the register
Submitted on 13 Nov 2023
Confirmation statement made on 14 March 2023 with updates
Submitted on 14 Mar 2023
Director's details changed for Michael Francis Crowley Iii on 9 March 2023
Submitted on 9 Mar 2023
Secretary's details changed for Michael Francis Crowley Iii on 3 March 2023
Submitted on 9 Mar 2023
Cessation of Parexel International Corporation Ltd. as a person with significant control on 1 January 2023
Submitted on 10 Jan 2023
Notification of a person with significant control statement
Submitted on 10 Jan 2023
Accounts for a small company made up to 31 December 2021
Submitted on 30 Sep 2022
Termination of appointment of David Claude Granese as a director on 12 August 2022
Submitted on 12 Aug 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year